FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2502912744> ?p ?o ?g. }

• W2502912744 abstract "Tumor initiating cells (TIC) are a small population of cancer cells with enhanced tumorigenicity and drug resistance. Their stemness properties could be activated by stress-induced cell plasticity but the mechanisms remain to be studied. Calcium signaling is important for integrating cell responses to intra- and extracellular stresses. The role of its downstream pathway, calcineurin/NFAT, in lung TIC has not been explored. This study investigated the role and mechanisms of calcineurin/NFAT in regulating TIC and drug resistance by analyzing NFATc2 expression in multiple TIC populations and functional evaluation using in vitro and in vivo models. In tumor spheres and TIC isolated by marker-based flow cytometry, NFATc2 showed overexpression and higher luciferase reporter activities. Knockdown of NFATc2 reduced TIC marker proportions and suppressed TIC properties including pluripotency genes expression, sphere formation, cell mobility and drug resistance in vitro. Xenograft models and limiting dilution assay showed shNFATc2 effectively suppressed tumorigenesis and reduced TIC frequency. Stable NFATc2 knockdown sensitized tumors to cisplatin and gefitinib treatment. In contrast, TIC-supportive effects were observed in vitro and in vivo when NFATc2 was overexpressed. Further, NFATc2 was activated in stable gefitinib or cisplatin resistant cell lines, and knockdown of NFATc2 sensitized them to drug treatment. These data implicated NFATc2 is involved in lung TIC maintenance and drug resistance. To further investigate the molecular mechanisms of how NFATc2 mediate these roles, we analyzed pluripotency genes and observed a significant correlation between NFATc2 and SOX2 expression in lung cancer cell lines and human lung carcinomas. Computational analysis predicted NFATc2 binding sequences in SOX2 regulatory regions. Detailed studies including luciferase reporter assay, site-directed mutagenesis and CHIP-qRCR confirmed NFATc2 could regulate SOX2 expression through binding to its enhancer. Furthermore, immunohistochemistry on human lung cancers showed significant correlation between expressions of SOX2 and the anti-oxidative stem cell marker ALDH, suggesting SOX2 regulates ALDH expression. In vitro, NFATc2 knockdown suppressed ALDH1A1 expression but it was rescued by SOX2 overexpression. Vice versa, ALDH1A1 was upregulated in NFATc2 overexpressing cells but this was prevented by SOX2 knockdown. Functionally, reactive oxidative species (ROS) levels assessed by flow cytometry were suppressed by activated NFATc2/SOX2/ALDH1A1 axis, while treatment with the ROS inhibitor N-acetylcysteine reversed the sensitization of shNFATc2 on cisplatin treatment. Together, the data showed NFATc2 is involved in the regulation of TIC phenotypes in lung cancer. It increases drug resistance by ROS scavenging mediated by the SOX2/ALDH1A1 axis. Citation Format: Zhi-Jie Xiao, Jing Liu, Vicky PC Tin, Maria P. Wong. The Calcineurin/NFAT pathway mediates tumor initiating cell and drug resistance in lung cancer through SOX2 enhancer binding and ALDH upregulation. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2482." @default.
• W2502912744 created "2016-08-23" @default.
• W2502912744 creator A5005282415 @default.
• W2502912744 creator A5023836777 @default.
• W2502912744 creator A5035282947 @default.
• W2502912744 creator A5055674151 @default.
• W2502912744 date "2016-07-15" @default.
• W2502912744 modified "2023-09-22" @default.
• W2502912744 title "Abstract 2482: The Calcineurin/NFAT pathway mediates tumor initiating cell and drug resistance in lung cancer through SOX2 enhancer binding and ALDH upregulation" @default.
• W2502912744 doi "https://doi.org/10.1158/1538-7445.am2016-2482" @default.
• W2502912744 hasPublicationYear "2016" @default.
• W2502912744 type Work @default.
• W2502912744 sameAs 2502912744 @default.
• W2502912744 citedByCount "0" @default.
• W2502912744 crossrefType "proceedings-article" @default.
• W2502912744 hasAuthorship W2502912744A5005282415 @default.
• W2502912744 hasAuthorship W2502912744A5023836777 @default.
• W2502912744 hasAuthorship W2502912744A5035282947 @default.
• W2502912744 hasAuthorship W2502912744A5055674151 @default.
• W2502912744 hasConcept C104317684 @default.
• W2502912744 hasConcept C107459253 @default.
• W2502912744 hasConcept C121608353 @default.
• W2502912744 hasConcept C126322002 @default.
• W2502912744 hasConcept C128057223 @default.
• W2502912744 hasConcept C145103041 @default.
• W2502912744 hasConcept C173396325 @default.
• W2502912744 hasConcept C185592680 @default.
• W2502912744 hasConcept C189938988 @default.
• W2502912744 hasConcept C207701140 @default.
• W2502912744 hasConcept C2777933648 @default.
• W2502912744 hasConcept C2911091166 @default.
• W2502912744 hasConcept C502942594 @default.
• W2502912744 hasConcept C54355233 @default.
• W2502912744 hasConcept C55493867 @default.
• W2502912744 hasConcept C555283112 @default.
• W2502912744 hasConcept C71924100 @default.
• W2502912744 hasConcept C81885089 @default.
• W2502912744 hasConcept C86339819 @default.
• W2502912744 hasConcept C86803240 @default.
• W2502912744 hasConceptScore W2502912744C104317684 @default.
• W2502912744 hasConceptScore W2502912744C107459253 @default.
• W2502912744 hasConceptScore W2502912744C121608353 @default.
• W2502912744 hasConceptScore W2502912744C126322002 @default.
• W2502912744 hasConceptScore W2502912744C128057223 @default.
• W2502912744 hasConceptScore W2502912744C145103041 @default.
• W2502912744 hasConceptScore W2502912744C173396325 @default.
• W2502912744 hasConceptScore W2502912744C185592680 @default.
• W2502912744 hasConceptScore W2502912744C189938988 @default.
• W2502912744 hasConceptScore W2502912744C207701140 @default.
• W2502912744 hasConceptScore W2502912744C2777933648 @default.
• W2502912744 hasConceptScore W2502912744C2911091166 @default.
• W2502912744 hasConceptScore W2502912744C502942594 @default.
• W2502912744 hasConceptScore W2502912744C54355233 @default.
• W2502912744 hasConceptScore W2502912744C55493867 @default.
• W2502912744 hasConceptScore W2502912744C555283112 @default.
• W2502912744 hasConceptScore W2502912744C71924100 @default.
• W2502912744 hasConceptScore W2502912744C81885089 @default.
• W2502912744 hasConceptScore W2502912744C86339819 @default.
• W2502912744 hasConceptScore W2502912744C86803240 @default.
• W2502912744 hasLocation W25029127441 @default.
• W2502912744 hasOpenAccess W2502912744 @default.
• W2502912744 hasPrimaryLocation W25029127441 @default.
• W2502912744 hasRelatedWork W1504313961 @default.
• W2502912744 hasRelatedWork W1991416812 @default.
• W2502912744 hasRelatedWork W1998389907 @default.
• W2502912744 hasRelatedWork W2052025930 @default.
• W2502912744 hasRelatedWork W2075190114 @default.
• W2502912744 hasRelatedWork W2103132731 @default.
• W2502912744 hasRelatedWork W2179660271 @default.
• W2502912744 hasRelatedWork W2341958805 @default.
• W2502912744 hasRelatedWork W2429050223 @default.
• W2502912744 hasRelatedWork W2546490688 @default.
• W2502912744 hasRelatedWork W2766224927 @default.
• W2502912744 hasRelatedWork W2802173909 @default.
• W2502912744 hasRelatedWork W2883745374 @default.
• W2502912744 hasRelatedWork W2904851566 @default.
• W2502912744 hasRelatedWork W2953661342 @default.
• W2502912744 hasRelatedWork W2992269609 @default.
• W2502912744 hasRelatedWork W2999434687 @default.
• W2502912744 hasRelatedWork W3047038659 @default.
• W2502912744 hasRelatedWork W3100276306 @default.
• W2502912744 hasRelatedWork W3092585885 @default.
• W2502912744 isParatext "false" @default.
• W2502912744 isRetracted "false" @default.
• W2502912744 magId "2502912744" @default.
• W2502912744 workType "article" @default.